Intrinsiqs

Is Aquestive Therapeutics, Inc. overvalued?

Aquestive Therapeutics, Inc. (AQST) — key valuation metrics and fundamentals.

No verdict
Price
$4.25
Fair value
Current P/E
Normal P/E
Market cap
$533.2M
Dividend yield
0.0%
Return on equity
190.9%
Sector
Healthcare

See the full interactive analysis →

Fair value compares AQST's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.